home / stock / abvc / abvc news


ABVC News and Press, ABVC BioPharma Inc. From 07/26/23

Stock Information

Company Name: ABVC BioPharma Inc.
Stock Symbol: ABVC
Market: NASDAQ
Website: abvcpharma.com

Menu

ABVC ABVC Quote ABVC Short ABVC News ABVC Articles ABVC Message Board
Get ABVC Alerts

News, Short Squeeze, Breakout and More Instantly...

ABVC - ARMP and VINC among mid-day movers

2023-07-26 12:59:58 ET Gainers: Vicor Corporation ( VICR ) +51% . Tupperware Brands Corporation ( TUP ) +43% . ABVC BioPharma ( ABVC ) +39% . Armata Pharmaceuticals ( ARMP ) +30% . PacWest Bancorp ( PACW ) +27% . XPeng ( XP...

ABVC - ABVC rises on acquisition of real estate assets for strategic investments

2023-07-26 11:02:56 ET ABVC BioPharma ( NASDAQ: ABVC ) trades 50% higher on Wednesday after it has signed a term sheet with Zhonghui United Technology Group Co to acquire real estates assets via an equity transfer, estimated at $7.4M. The deal aims to advance the dev...

ABVC - ABVC BioPharma, Benitec top healthcare gainers; Carmell, 180 Life Sciences among losers

2023-07-26 10:37:58 ET Gainers: ABVC BioPharma ( ABVC ) +50% . Benitec Biopharma ( BNTC ) +45% . Tilray Brands ( TLRY ) +23% . Teladoc Health ( TDOC ) +21% . Biodexa Pharmaceuticals ( BDRX ) +8% . Losers: Carmell Ther...

ABVC - Micro Cap Soars On Strategic Investment Announcement

2023-07-26 09:33:07 ET While we normally talk about stocks that are trading sub-$5, seeing that this particular stock closed at $3.80 yesterday, we couldn’t help but bring it up this morning, regardless of how high it’s trading right now! A California-based %Biotech fi...

ABVC - ABVC Signs Term Sheet to Acquire Real Estate Assets for Strategic Investments

FREMONT, CA - ( NewMediaWire ) - July 26, 2023 -   ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, Neurology, and Ophthalmology, announced today that it has signed a term sheet to adva...

ABVC - ABVC BioPharma Announces Reverse Stock Split

FREMONT, CA - ( NewMediaWire ) - July 24, 2023 -   ABVC BioPharma, Inc.  (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, and oncology/hematology, today announced a reverse stock split of its common ...

ABVC - ABVC BioPharma CEO to forgo salary

2023-07-06 09:12:03 ET ABVC BioPharma ( NASDAQ: ABVC ) said on Thursday that its CEO, Uttam Patil, had decided to forgo his salary. Patil had instead chosen to receive stock options as a part of his compensation package. Press Release For further details see...

ABVC - The New CEO of ABVC BioPharma Takes Steps to Help Improve Cash Efficiency

FREMONT, CA - ( NewMediaWire ) - July 06, 2023 -   ABVC BioPharma, Inc.  (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced the visionary new CEO of ABVC has selflessly c...

ABVC - ABVC BioPharma names Patil as new CEO

2023-06-26 11:07:25 ET ABVC BioPharma ( NASDAQ: ABVC ) has appointed Uttam Yashwant Patil as its new chief executive officer, the company said Monday. Patil's employment with ABVC began on June 23, the company said. Press Release . For furth...

ABVC - ABVC BioPharma, Inc. Announces New CEO as It Targets Further Growth

FREMONT, CA - ( NewMediaWire ) - June 26, 2023 - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced the appointment of Dr. Uttam Yashwant Patil (Dr. Uttam)   a...

Previous 10 Next 10